Najarian JS - Search Results

1

ABO-compatible mismatching decreases 5-year actuarial graft survival after renal transplantation.

Stock PG, Sutherland DE, Fryd DS, Ascher NL, Payne W, Simmons RL, Najarian JS. Stock PG, et al. Among authors: najarian js. Transplant Proc. 1987 Dec;19(6):4522-4. Transplant Proc. 1987. PMID: 3321612 No abstract available.

2

Predicting long-term kidney graft survival: can new trials be performed?

Paraskevas S, Kandaswamy R, Humar A, Gillingham K, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DE, Matas AJ. Paraskevas S, et al. Among authors: najarian js. Transplantation. 2003 Apr 27;75(8):1256-9. doi: 10.1097/01.TP.0000060740.69785.09. Transplantation. 2003. PMID: 12717212

3

Influence of pretransplant cytomegalovirus serology and treatment of rejection upon disease after kidney and kidney plus pancreas transplantation.

Mayoral JL, Brayman KL, Gillingham KJ, Sutherland DE, Najarian JS, Dunn DL. Mayoral JL, et al. Among authors: najarian js. Transplant Proc. 1992 Jun;24(3):929-31. Transplant Proc. 1992. PMID: 1318594 Clinical Trial. No abstract available.

4

Pancreas transplantation--1991.

Najarian JS, Sutherland DE. Najarian JS, et al. Transplant Proc. 1992 Aug;24(4):1293-6. Transplant Proc. 1992. PMID: 1496566 Review. No abstract available.

5

Retransplantation as a risk factor for lymphocele formation.

Stephanian E, Matas AJ, Gores P, Sutherland DE, Najarian JS. Stephanian E, et al. Among authors: najarian js. Transplantation. 1992 Mar;53(3):676-8. doi: 10.1097/00007890-199203000-00035. Transplantation. 1992. PMID: 1549865 No abstract available.

6

Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients.

Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Frey DJ, et al. Among authors: najarian js. Transplantation. 1992 Jul;54(1):50-6. doi: 10.1097/00007890-199207000-00008. Transplantation. 1992. PMID: 1631944 Clinical Trial.

7

Risk factors for second renal allografts immunosuppressed with cyclosporine.

Almond PS, Matas AJ, Gillingham K, Troppmann C, Payne W, Dunn D, Sutherland D, Najarian JS. Almond PS, et al. Among authors: najarian js. Transplantation. 1991 Aug;52(2):253-8. doi: 10.1097/00007890-199108000-00013. Transplantation. 1991. PMID: 1871798

8

MALG vs OKT3 following renal transplantation: a randomized prospective trial.

Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Frey DJ, et al. Among authors: najarian js. Transplant Proc. 1991 Feb;23(1 Pt 2):1048-9. Transplant Proc. 1991. PMID: 1899149 Clinical Trial. No abstract available.

9

Long-term outlook for renal transplant recipients with one-year function. "Doctor, what are my chances"?

Fischel RJ, Payne WD, Gillingham KJ, Dunn DL, Sutherland DE, Matas AJ, Najarian JS. Fischel RJ, et al. Among authors: najarian js. Transplantation. 1991 Jan;51(1):118-22. doi: 10.1097/00007890-199101000-00018. Transplantation. 1991. PMID: 1987680

10

Kidney retransplantation: patients with a failed second kidney transplant should be considered for a third transplant.

Fasola CG, Kim YS, Morel P, Dunn DL, Sutherland DE, Payne WD, Matas AJ, Najarian JS. Fasola CG, et al. Among authors: najarian js. Transplant Proc. 1991 Feb;23(1 Pt 2):1336. Transplant Proc. 1991. PMID: 1989232 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

974 results

Search Page

Filters